SEC Form 4 · accession 0001562180-15-000723
Sage Therapeutics, Inc. · SAGE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven M Paul
Director
Period of report
Sep 1, 2015
Accepted (ET)
Sep 2, 2015 · 3:43 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001597553
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Sep 1, 2015 | S | 10,482 | $52.69 | D | 693,168 | D | |
| Common StockF3 | Sep 1, 2015 | S | 9,518 | $52.10 | D | 683,650 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- F2This transaction was executed in multiple trades at prices ranging from $52.26 USD to $53.26 USD. The price reported above reflects the weighted average sale price.
- F3This transaction was executed in multiple trades at prices ranging from $51.83 USD to $52.25 USD. The price reported above reflects the weighted average sale price.